department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ESTRING · pharmadog

pharmadog
drugs
ESTRING

drug · small molecule

patient view →

ESTRING

updated 2mo ago

/ ES-trə-DY-ohl /

by $PFE PFIZER INC🔗 ChEMBL

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 12 approved and 41 investigational indications.

targets

Estrogen receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

ESTRING

trade names

Adgyn estro, Alora, Aquagen, Bedol, Climara, Dermestril 100

generic

ESTRADIOL

MOA

Estrogen receptor alpha agonist

indication

INDICATIONS AND USAGE ESTRING is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 39m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 8

tagApproval204 co-mentions · 63 sources
drugNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE76 co-mentions · 18 sources
drugNORGESTIMATE AND ETHINYL ESTRADIOL71 co-mentions · 18 sources
drugDAYSEE62 co-mentions · 18 sources
tagSmall Molecule52 co-mentions · 37 sources
drugnorethindrone21 co-mentions · 13 sources
tagRecall13 co-mentions · 12 sources
drugORIAHNN (COPACKAGED)10 co-mentions · 5 sources

Trials studying ESTRING

phase1Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)recruitingn=24
phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesityrecruitingn=50
phase3The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trialrecruitingn=110
phase1A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participantsrecruitingn=16
phase1A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptivesactive not recruitingn=20
phase1A Study of Elenestinib in Healthy Adult Female Participantscompletedn=20
phase1Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)completedn=24
phase4Menopausal HT for Women Living With HIV (HoT)not yet recruitingn=105

more trials →